Brinker Capital Investments, LLC Repligen Corp Transaction History

Brinker Capital Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$140.68 - $188.02 $47,690 - $63,738	339 Added 22.95%	1,816 $295,000
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $38,202 - $61,136	-237 Reduced 13.83%	1,477 $278,000
Q4 2021 Feb 08, 2022	BUY	$247.59 - $304.47 $247 - $304	1 Added 0.06%	1,714 $454,000
Q2 2021 Aug 03, 2021	BUY	$165.87 - $220.95 $5,639 - $7,512	34 Added 2.03%	1,713 $342,000
Q1 2021 May 12, 2021	SELL	$180.37 - $226.26 $254,502 - $319,252	-1,411 Reduced 45.66%	1,679 $326,000
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $236,039 - $329,272	1,594 Added 106.55%	3,090 $592,000
Q3 2020 Dec 03, 2020	BUY	$122.51 - $158.27 $183,274 - $236,771	1,496 New	1,496 $221,000

482

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.73B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.